Mutations in the MLH1 and MSH2 genes have a greater effect on DNA repair and more frequently contribute to the manifestation of the typical CRCs found in individuals with LS, while mutations in PMS2 and MSH6 have distinct risks and patterns of development of intestinal and extracolonic malignant processes [28,29,30,31,32]. The gene discussed is PMS2; the disease is Leigh syndrome.